January 28th, 2015, Ash Stevens manufacturing facility in Riverview, Michigan approved by FDA for the manufacture of Amotosalen, the API in Cerus Corporation's INTERCEPT Blood System.
View PDF for full details
If you would like to arrange a meeting with Ash Stevens at an event, please contactAmar Karandikar, Vice President of Business Development, North America
Call Our Team +1 734 282 3370Email Our Team >
© 2016 Ash Stevens. All Rights Reserved.